Zirui Wan

834 total citations
30 papers, 647 citations indexed

About

Zirui Wan is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Zirui Wan has authored 30 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Zirui Wan's work include Cytomegalovirus and herpesvirus research (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Zirui Wan is often cited by papers focused on Cytomegalovirus and herpesvirus research (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Zirui Wan collaborates with scholars based in China, Malaysia and United States. Zirui Wan's co-authors include Yali Lv, Lili Gong, Lihong Liu, Feifei Han, Lulu Ren, He Liu, Lingling Xuan, Song Yang, Wen Zhang and Guo Wang and has published in prestigious journals such as Free Radical Biology and Medicine, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Zirui Wan

30 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zirui Wan China 17 233 158 93 83 78 30 647
Bolin Li China 11 209 0.9× 111 0.7× 50 0.5× 72 0.9× 59 0.8× 51 613
Mei Meng China 18 397 1.7× 108 0.7× 115 1.2× 121 1.5× 76 1.0× 51 824
Kuan‐Ho Lin Taiwan 16 274 1.2× 175 1.1× 94 1.0× 44 0.5× 71 0.9× 39 788
Mostafa Vaghari‐Tabari Iran 16 369 1.6× 105 0.7× 171 1.8× 81 1.0× 59 0.8× 27 840
Qi He China 17 280 1.2× 94 0.6× 91 1.0× 60 0.7× 106 1.4× 61 730
Keshu Xu China 17 303 1.3× 377 2.4× 83 0.9× 69 0.8× 56 0.7× 27 768
Shuling Zhang China 16 153 0.7× 207 1.3× 56 0.6× 96 1.2× 135 1.7× 43 745
John Malaty United States 8 185 0.8× 223 1.4× 129 1.4× 99 1.2× 59 0.8× 33 687

Countries citing papers authored by Zirui Wan

Since Specialization
Citations

This map shows the geographic impact of Zirui Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zirui Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zirui Wan more than expected).

Fields of papers citing papers by Zirui Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zirui Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zirui Wan. The network helps show where Zirui Wan may publish in the future.

Co-authorship network of co-authors of Zirui Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Zirui Wan. A scholar is included among the top collaborators of Zirui Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zirui Wan. Zirui Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xuan, Lingling, Lulu Ren, Wen Zhang, Zirui Wan, & Yali Lv. (2025). PANoptosis in acute asthma exacerbation: Identification of key genes and immune dysregulation. European Journal of Pharmacology. 1008. 178308–178308. 1 indexed citations
2.
Wan, Zirui, Pengfei Li, Dan Liu, et al.. (2022). Metabolic, genetic, and pharmacokinetic parameters for the prediction of olanzapine efficacy. European Journal of Pharmaceutical Sciences. 177. 106277–106277. 3 indexed citations
3.
Guo, Lifang, et al.. (2020). Influence of CYP2D6*5 and *10 polymorphism on the pharmacokinetics of nebivolol in healthy Chinese subjects. Journal of Clinical Pharmacy and Therapeutics. 45(4). 632–637. 7 indexed citations
4.
Xuan, Lingling, Feifei Han, Lili Gong, et al.. (2020). Ceramide induces MMP-9 expression through JAK2/STAT3 pathway in airway epithelium. Lipids in Health and Disease. 19(1). 196–196. 16 indexed citations
5.
Lv, Yali, Zirui Wan, Song Yang, et al.. (2020). Curcumin inhibits the formation of atherosclerosis in ApoE mice by suppressing cytomegalovirus activity in endothelial cells. Life Sciences. 257. 117658–117658. 21 indexed citations
6.
Ren, Lulu, Lingling Xuan, Feifei Han, et al.. (2020). Vitamin D supplementation rescues simvastatin induced myopathy in mice via improving mitochondrial cristae shape. Toxicology and Applied Pharmacology. 401. 115076–115076. 17 indexed citations
7.
Xuan, Lingling, Lulu Ren, Feifei Han, et al.. (2019). Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production. Inflammation. 43(1). 326–335. 6 indexed citations
8.
Tang, Li, Yu‐Ligh Liou, Zirui Wan, et al.. (2019). Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy. 120. 109488–109488. 34 indexed citations
9.
Yang, Song, Wen Zhang, Lingling Xuan, et al.. (2019). Akebia Saponin D inhibits the formation of atherosclerosis in ApoE mice by attenuating oxidative stress-induced apoptosis in endothelial cells. Atherosclerosis. 285. 23–30. 32 indexed citations
10.
Ren, Lulu, Feifei Han, Lingling Xuan, et al.. (2019). Clusterin ameliorates endothelial dysfunction in diabetes by suppressing mitochondrial fragmentation. Free Radical Biology and Medicine. 145. 357–373. 40 indexed citations
11.
Gong, Lili, Song Yang, He Liu, et al.. (2018). Anti-nociceptive and anti-inflammatory potentials of Akebia saponin D. European Journal of Pharmacology. 845. 85–90. 39 indexed citations
12.
Xuan, Lingling, Feifei Han, Lili Gong, et al.. (2018). Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis. Lipids in Health and Disease. 17(1). 263–263. 51 indexed citations
13.
Lv, Yali, Feifei Han, Zirui Wan, et al.. (2017). Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis. Infection and Drug Resistance. Volume 10. 511–519. 35 indexed citations
14.
Han, Feifei, Yali Lv, Lili Gong, et al.. (2017). VDR Gene variation and insulin resistance related diseases. Lipids in Health and Disease. 16(1). 157–157. 40 indexed citations
15.
Gong, Lili, Song Yang, Feifei Han, et al.. (2017). Akebia saponin D alleviates hepatic steatosis through BNip3 induced mitophagy. Journal of Pharmacological Sciences. 136(4). 189–195. 38 indexed citations
16.
Lv, Yali, Feifei Han, Lili Gong, et al.. (2016). Human cytomegalovirus infection and vascular disease risk: A meta-analysis. Virus Research. 227. 124–134. 15 indexed citations
17.
Gong, Lili, Wen Zhang, He Liu, et al.. (2016). Akebia Saponin D Decreases Hepatic Steatosis through Autophagy Modulation. Journal of Pharmacology and Experimental Therapeutics. 359(3). 392–400. 34 indexed citations
18.
Wan, Zirui, Qi Pei, Yan Peng, et al.. (2015). Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote. Journal of Pharmacology and Experimental Therapeutics. 354(3). 310–315. 42 indexed citations
19.
Gan, Siew Hua, et al.. (2003). Standard CYP2D6 genotyping procedures fail for the CYP2D6*5 and duplication alleles when hair roots are used as a source of DNA. Clinica Chimica Acta. 329(1-2). 61–68. 4 indexed citations
20.
Gan, Siew Hua, et al.. (2002). Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects. Journal of Pharmaceutical and Biomedical Analysis. 30(2). 189–195. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bolin Li Breakdown of academic impact, for papers by Mei Meng Breakdown of academic impact, for papers by Kuan‐Ho Lin Breakdown of academic impact, for papers by Mostafa Vaghari‐Tabari Breakdown of academic impact, for papers by Qi He Breakdown of academic impact, for papers by Keshu Xu Breakdown of academic impact, for papers by Shuling Zhang Breakdown of academic impact, for papers by John Malaty
Rankless by CCL
2026